155 related articles for article (PubMed ID: 25952979)
21. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.
Regine WF; Schmitt FA; Scott CB; Dearth C; Patchell RA; Nichols RC; Gore EM; Franklin RL; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1346-52. PubMed ID: 15050309
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
23. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
[TBL] [Abstract][Full Text] [Related]
24. Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy.
Rush S; Elliott RE; Morsi A; Mehta N; Spriet J; Narayana A; Donahue B; Parker EC; Golfinos JG
J Neurosurg; 2011 Jul; 115(1):37-48. PubMed ID: 21417707
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).
Saw RP; Armstrong BK; Mason RS; Morton RL; Shannon KF; Spillane AJ; Stretch JR; Thompson JF
BMC Cancer; 2014 Oct; 14():780. PubMed ID: 25343963
[TBL] [Abstract][Full Text] [Related]
26. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
[TBL] [Abstract][Full Text] [Related]
27. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
[TBL] [Abstract][Full Text] [Related]
28. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
Li J; Bentzen SM; Li J; Renschler M; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
[TBL] [Abstract][Full Text] [Related]
29. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
[TBL] [Abstract][Full Text] [Related]
32. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
[TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical outcomes of surgery followed by local brain radiotherapy and surgery followed by whole brain radiotherapy in patients with single brain metastasis: single-center retrospective analysis.
Hashimoto K; Narita Y; Miyakita Y; Ohno M; Sumi M; Mayahara H; Kayama T; Shibui S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e475-80. PubMed ID: 21477934
[TBL] [Abstract][Full Text] [Related]
34. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
35. Gamma knife radiosurgery for the treatment of cystic cerebral metastases.
Ebinu JO; Lwu S; Monsalves E; Arayee M; Chung C; Laperriere NJ; Kulkarni AV; Goetz P; Zadeh G
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):667-71. PubMed ID: 22885145
[TBL] [Abstract][Full Text] [Related]
36. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity.
Radbill AE; Fiveash JF; Falkenberg ET; Guthrie BL; Young PE; Meleth S; Markert JM
Cancer; 2004 Aug; 101(4):825-33. PubMed ID: 15305416
[TBL] [Abstract][Full Text] [Related]
37. Poor outcomes after whole brain radiotherapy in patients with brain metastases: results from an international multicentre cohort study.
Windsor AA; Koh ES; Allen S; Gabriel GS; Yeo AE; Allison R; van der Linden YM; Barton MB
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):674-80. PubMed ID: 23906722
[TBL] [Abstract][Full Text] [Related]
38. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial.
Bartula I; Tran AD; Nowak AK; Ahmed T; Morton RL; Burmeister BH; Dolven-Jacobsen K; Nobes J; Thompson JF; Fogarty GB; Lo SN; Hong AM
Clin Transl Radiat Oncol; 2023 Jul; 41():100597. PubMed ID: 37441544
[TBL] [Abstract][Full Text] [Related]
40. In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely.
Pinkham MB; Sahgal A; Pullar AP; Foote MC
BMC Cancer; 2017 Nov; 17(1):768. PubMed ID: 29141597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
